Home
>
US Stocks
>
Acadia Pharmaceuticals Inc
Acadia Pharmaceuticals Inc
ACAD

Acadia Pharmaceuticals Inc (ACAD)

$18.113.13%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$17.54
Today Low/High$17.54 / $18.11
52 Week Low/High$15.68 / $57.46
P/E ratio-10.71
Market Cap$2.82B

Company Details

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years it has been working at the forefront of healthcare to bring vital solutions to people who need them most. It developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson's disease psychosis. Its late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research it is exploring novel approaches to pain management, and cognition and neuropsychiatric symptoms in central nervous system disorders.
OrganisationAcadia Pharmaceuticals Inc
HeadquatersSan Diego, California, US
Employees601
IndustryHealth Technology
CEOStephen Davis

Discover more

Frequently Asked Questions

What is Acadia Pharmaceuticals Inc (ACAD) share price today?

Can Indians buy Acadia Pharmaceuticals Inc (ACAD) shares?

How can I buy Acadia Pharmaceuticals Inc (ACAD) shares from India?

Can Fractional shares of Acadia Pharmaceuticals Inc (ACAD) be purchased?

What are the documents required to start investing in Acadia Pharmaceuticals Inc (ACAD) stocks?

We are a SEBI registered investement advisor